Symbols

NRXP

NRx Pharmaceuticals·NASDAQ

--(--)

NRXP Filings

2026-03-24 · Earnings Call

NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript

2026-03-24 · Key Events

Form 8-K - Current report

2026-03-23 · Financials

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

2026-02-24 · Key Events

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-02-23 ·

Form ARS - Annual Report to Security Holders

2026-02-23 · Key Events

Form DEF 14A - Other definitive proxy statements

2026-02-17 · Ownership

Form 4 - Statement of changes in beneficial ownership of securities

2026-02-17 · Ownership

Form 3 - Initial statement of beneficial ownership of securities

2026-02-17 · Key Events

Form 8-K - Current report

2026-02-17 ·

Form 424B5 - Prospectus [Rule 424(b)(5)]